StemCyte Overview
- Year Founded
-
1997
- Status
-
Public
- Employees
-
176
- Stock Symbol
-
4178
- Share Price
-
$0.47
- (As of Friday Closing)
StemCyte General Information
Description
StemCyte International Ltd is engaged in developing new stem cell drugs and test, process, and store umbilical cord blood (UCB)-related cells. The company's main operating activities are providing umbilical cord blood collection, processing and storage services. Its reportable segments are the United States, Taiwan, and Others. The majority of revenue is derived from the United States.
Contact Information
Website
www.stemcyte.comCorporate Office
- 13800 Live Oak Avenue
- Baldwin Park, CA 91706
- United States
Corporate Office
- 13800 Live Oak Avenue
- Baldwin Park, CA 91706
- United States
StemCyte Stock Performance
As of 13-Nov-2026, StemCyte’s stock price is $0.47. Its current market cap is $101M with 216M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.47 | $0.46 | $0.45 - $1.09 | $101M | 216M | 177K | -$0.03 |
StemCyte Financials Summary
As of 30-Jun-2026, StemCyte has a trailing 12-month revenue of $11.5M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 63,665 | 130,747 | ||
| Revenue | 11,462 | 11,826 | 11,925 | 11,647 |
| EBITDA | (5,782) | (5,687) | (6,026) | (9,414) |
| Net Income | (5,770) | (5,668) | (6,409) | (10,266) |
| Total Assets | 108,345 | 98,812 | 102,409 | 65,640 |
| Total Debt | 5,675 | 6,985 | 7,576 | 1,906 |
StemCyte Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
StemCyte Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
StemCyte Comparisons
Industry
Financing
Details
StemCyte Competitors (5)
One of StemCyte’s 5 competitors is Cord Blood Registry, a Formerly PE-Backed company based in Los Angeles, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cord Blood Registry | Formerly PE-Backed | Los Angeles, CA | ||||
| Viacord | Corporate Backed or Acquired | Waltham, MA | ||||
| LifeCell (Healthcare Services) | Venture Capital-Backed | Chennai, India | ||||
| Cryo-Cell International | Corporation | Oldsmar, FL | ||||
| Cordlife Group | Formerly PE-Backed | Singapore, Singapore |
StemCyte Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
StemCyte Patents
StemCyte Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20250312383-A1 | Human umbilical cord blood for use in alleviating fatigue | Pending | 05-Apr-2024 | ||
| WO-2025212986-A1 | Human umbilical cord blood for use in alleviating fatigue | Pending | 05-Apr-2024 | ||
| JP-2022544781-A | Treatment of cardiovascular disease | Active | 20-Aug-2019 | ||
| JP-7744897-B2 | Treatment of cardiovascular disease | Active | 20-Aug-2019 | ||
| AU-2020332352-A1 | Treatment of cardiovascular diseases | Pending | 20-Aug-2019 | A61K35/51 |
StemCyte Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
StemCyte ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Services
Subindustry
Rank
Percentile
StemCyte FAQs
-
When was StemCyte founded?
StemCyte was founded in 1997.
-
Where is StemCyte headquartered?
StemCyte is headquartered in Baldwin Park, CA.
-
What is the size of StemCyte?
StemCyte has 176 total employees.
-
What industry is StemCyte in?
StemCyte’s primary industry is Biotechnology.
-
Is StemCyte a private or public company?
StemCyte is a Public company.
-
What is StemCyte’s stock symbol?
The ticker symbol for StemCyte is 4178.
-
What is the current stock price of StemCyte?
As of 13-Nov-2026 the stock price of StemCyte is $0.47.
-
What is the current market cap of StemCyte?
The current market capitalization of StemCyte is $101M.
-
What is StemCyte’s current revenue?
The trailing twelve month revenue for StemCyte is $11.5M.
-
Who are StemCyte’s competitors?
Cord Blood Registry, Viacord, LifeCell (Healthcare Services), Cryo-Cell International, and Cordlife Group are competitors of StemCyte.
-
What is StemCyte’s annual earnings per share (EPS)?
StemCyte’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
